Pharma Focus Asia

Edge Pharmacy Services Announces US$ 1.5m Expansion of its Manufacturing Facility


Edge Pharmacy Services invests US$ 1.5 Million to expand its manufacturing capabilities to include an additional 20, 000 square feet of space.


Edge is known manufacturing a wide variety of compounded pharmaceuticals with specific focuses in operating room anesthesia, medications for ophthalmic surgery, ENT, dermatology, and allergy treatment.

The company plans for the long term solution and it invests over $1.5 million into expanding production capacity. In addition, new capabilities implemented during the expansion will enhance production capacity by 5 times when compared to its current capacity.

With the expansion of its manufacturing facility, Edge plans to keep pace with the production demands.

It is very typical for Edge not only to bring hospitals and surgery centres into compliance with these new regulations, but also save them hundreds of thousands of dollars per year in pharmaceutical costs.

Edge has been diligent in complying with new rules and regulations implemented by the Boards of Pharmacy, the Food and Drug Administration, USP-795, and USP-797.

Edge's 2017 facility expansion is the latest effort and commitment to continue those standards.


NameEdge Pharmacy Services
LocationColchester, VT, USA
Estimated CostUS$ 1.5 million
Parties InvolvedEdge Pharmacy Services
magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference